Drug Profile
Somatropin - Cangene
Alternative Names: Accretropin; rhGH - CangeneLatest Information Update: 24 Sep 2021
Price :
$50
*
At a glance
- Originator Cangene Corporation
- Developer Apotex; Emergent BioSolutions
- Class Growth hormones; Hormonal replacements; Obesity therapies; Recombinant proteins
- Mechanism of Action Human growth hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Short stature; Somatotropin deficiency
Most Recent Events
- 04 Jun 2015 Discontinued - Registered for Short stature in USA (SC)
- 04 Jun 2015 Discontinued - Registered for Somatotropin deficiency (In children) in USA (SC)
- 21 Feb 2014 Cangene Corporation has been acquired and merged into Emergent BioSolutions